Company Aggregate Debt: notablelabs.com (NTBL)

Notable Labs, Ltd. (NTBL) creates a precision oncology screening environment using AI to analyze live cells, which locks pharmaceutical companies into its software. The stock's price history reflects debt dynamics, which stand at 0.00, while the platform helps physicians calculate therapy success in advance. The company is currently scaling its services, helping partners predict the body's reaction to drugs prior to therapy.

Company Aggregate Debts: Notable Labs (NTBL) for 02/21/2024 - 11/02/2024

Analytical breakdowns and data insights for company Notable Labs (NTBL)

- price and consensus price forecast:
Stock Price Notable Labs Corp|NTBL - Price Target Chart
- market capitalization data:
Market Capitalization Notable Labs Inc.|NTBL - Enterprise Value
- book capitalization data:
Accounting Value per Share Notable Labs|NTBL - Book Capitalization|Market-to-Book Ratio notablelabs.com|NTBL - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Notable Labs, Ltd.|NTBL - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Notable Labs Ltd|NTBL - Company Aggregate Debts|Debt to Book Value Notable Labs Inc.|NTBL - Company Long-Term Liabilities|Company Short-Term Debts Notable Labs
Summary company analytics:NTBL (Notable Labs Corp)

This indicator captures the total volume of borrowed funds, allowing for an assessment of the balance between financial stability and the use of a tax shield for capital optimization. By analyzing the overall state of liabilities, an investor can confirm the macro-stability of Notable Labs, Ltd. (NTBL), whose non-cyclical nature in the field of cancer therapy and reliance on payments from pharma behemoths minimize debt load risks even during periods of market volatility.

Competing companies

Company Aggregate Debts ONC (BeiGene Oncology)|HALO - Company Debts|Company Aggregate Debt revmed.com RVMD|AAPG: Company Aggregate Debts|CGON - Company Total Debt|Company Aggregate Debts URGN|BCAX (Bicara Corp) - Company Cumulative Debt|PSNL - Company Debts|Aggregate Debt Obligations erasca.com (ERAS)|Delcath Systems (DCTH) - Company Total Debt|Aggregate Debt Obligations Y-mAbs Therapeutics Inc (YMAB)|Aura Bio - Company Aggregate Debts|CADL - Company Total Debt|Accuray Incorporated - Company Total Debt|SLS: Company Aggregate Debts|Company Debts Actuate Therapeutics ACTU|Citius Oncology Inc. (CTOR) - Aggregate Debt Obligations|Company Aggregate Debts HURA (TuHURA Biosciences Inc.)|Company Cumulative Debt TARA|Company Debts Fate Therapeutics, Inc. FATE|Company Aggregate Debt WHWK (aadibio.com)|TCRX: Company Debts|CSBR - Company Cumulative Debt|Company Total Debt XBiotech USA XBIT|CVM - Company Cumulative Indebtedness|OSTX: Company Aggregate Debts|radiopharmtheranostics.com (RADX) - Company Aggregate Debts|Company Aggregate Debts Artiva Biotherapeutics Inc.|Company Debts ANL|Company Debts Veru Pharma (VERU)|Company Debts Tempest Therapeutics Corp (TPST)|XLO: Company Aggregate Debts|RENB - Company Cumulative Debt|Company Total Debt Mural Bio (MURA)|KAPA: Aggregate Debt Obligations|onkuretherapeutics.com (OKUR) - Company Debts|CytoMed Therapeutics Limited (GDTC) - Company Debts|CRIS (Curis Inc.) - Company Aggregate Debts|Company Aggregate Debts Apollomics Corp|Company Aggregate Debts Tharimmune (THAR)|Company Debts ADVB (advanbiomed.com)|Company Debts GNPX|CLDI - Company Total Debt Obligations|Company Total Debt Sunshine Biopharma, Inc. (SBFM)|XBIO: Aggregate Debt Obligations|Salarius Pharmaceuticals, Inc. (SLRX) - Company Debts|Company Debts Purple Biotech Ltd|American Oncology Network Inc (AONC) - Company Total Debt|Company Cumulative Indebtedness BeiGene Ltd|Company Aggregate Debts Checkpoint Therapeutics CKPT|Company Aggregate Debt elevationoncology.com ELEV|Company Total Debt ICAD|Ikena Oncology Inc. - Company Total Debt Obligations|Viracta (VIRX) - Company Debts|MorphoSys Corporation (MOR) - Company Aggregate Debt|NAYA - Company Total Debt|ascentage.com (AAPGV) - Company Cumulative Indebtedness